Cystatin C promotes tau protein phosphorylation and causes microtubule instability by inhibiting intracellular turnover of GSK3β in neurons

In Alzheimer's disease (AD) tau protein hyperphosphorylation causes neurofibrillary tangle formation, microtubule instability and neurodegeneration. Determining the mechanism of tau hyperphosphorylation will provide a better understanding of AD pathology. Cystatin C (CysC) is a risk factor for...

Full description

Saved in:
Bibliographic Details
Published in:Molecular and cellular neuroscience Vol. 89; pp. 1 - 8
Main Authors: Duan, Jinhai, Marcellus, Kristen A., Qin, Xike, Wang, Yunling, Paudel, Hemant K.
Format: Journal Article
Language:English
Published: United States Elsevier Inc 01-06-2018
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract In Alzheimer's disease (AD) tau protein hyperphosphorylation causes neurofibrillary tangle formation, microtubule instability and neurodegeneration. Determining the mechanism of tau hyperphosphorylation will provide a better understanding of AD pathology. Cystatin C (CysC) is a risk factor for late-onset AD and its level is upregulated in the brains of AD patients. The role of CysC is AD pathogenesis is not known. In this study, we found that CysC level is upregulated in 3xTg-AD mouse brain. We demonstrate that CysC does not affect cellular Aβ production. However, when overexpressed in neuron (NGF-differentiated PC12 cells), CysC inhibits turnover of GSK3β, promotes GSK3β-catalyzed tau phosphorylation at Ser396/404 and causes microtubule instability. Our data provide a novel insight into the role of CysC in AD pathogenesis. •Cystatin C is one of the risk factors for LOAD.•Cystatin C does not affect Aβ production in HEK-293 cells.•Cystatin C promotes GSK3β-catalyzed tau protein phosphorylation in neurons.•Cystatin C inhibits cellular degradation of GSK3β.
AbstractList In Alzheimer's disease (AD) tau protein hyperphosphorylation causes neurofibrillary tangle formation, microtubule instability and neurodegeneration. Determining the mechanism of tau hyperphosphorylation will provide a better understanding of AD pathology. Cystatin C (CysC) is a risk factor for late-onset AD and its level is upregulated in the brains of AD patients. The role of CysC is AD pathogenesis is not known. In this study, we found that CysC level is upregulated in 3xTg-AD mouse brain. We demonstrate that CysC does not affect cellular Aβ production. However, when overexpressed in neuron (NGF-differentiated PC12 cells), CysC inhibits turnover of GSK3β, promotes GSK3β-catalyzed tau phosphorylation at Ser396/404 and causes microtubule instability. Our data provide a novel insight into the role of CysC in AD pathogenesis.
In Alzheimer's disease (AD) tau protein hyperphosphorylation causes neurofibrillary tangle formation, microtubule instability and neurodegeneration. Determining the mechanism of tau hyperphosphorylation will provide a better understanding of AD pathology. Cystatin C (CysC) is a risk factor for late-onset AD and its level is upregulated in the brains of AD patients. The role of CysC is AD pathogenesis is not known. In this study, we found that CysC level is upregulated in 3xTg-AD mouse brain. We demonstrate that CysC does not affect cellular Aβ production. However, when overexpressed in neuron (NGF-differentiated PC12 cells), CysC inhibits turnover of GSK3β, promotes GSK3β-catalyzed tau phosphorylation at Ser and causes microtubule instability. Our data provide a novel insight into the role of CysC in AD pathogenesis.
In Alzheimer's disease (AD) tau protein hyperphosphorylation causes neurofibrillary tangle formation, microtubule instability and neurodegeneration. Determining the mechanism of tau hyperphosphorylation will provide a better understanding of AD pathology. Cystatin C (CysC) is a risk factor for late-onset AD and its level is upregulated in the brains of AD patients. The role of CysC is AD pathogenesis is not known. In this study, we found that CysC level is upregulated in 3xTg-AD mouse brain. We demonstrate that CysC does not affect cellular Aβ production. However, when overexpressed in neuron (NGF-differentiated PC12 cells), CysC inhibits turnover of GSK3β, promotes GSK3β-catalyzed tau phosphorylation at Ser396/404 and causes microtubule instability. Our data provide a novel insight into the role of CysC in AD pathogenesis. •Cystatin C is one of the risk factors for LOAD.•Cystatin C does not affect Aβ production in HEK-293 cells.•Cystatin C promotes GSK3β-catalyzed tau protein phosphorylation in neurons.•Cystatin C inhibits cellular degradation of GSK3β.
Author Wang, Yunling
Paudel, Hemant K.
Qin, Xike
Duan, Jinhai
Marcellus, Kristen A.
Author_xml – sequence: 1
  givenname: Jinhai
  surname: Duan
  fullname: Duan, Jinhai
  organization: Department of Neurology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangdong Institute of Geriatrics, Guangdong Institute of Neurosciences, Guangzhou 510080, China
– sequence: 2
  givenname: Kristen A.
  surname: Marcellus
  fullname: Marcellus, Kristen A.
  organization: Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, Quebec H4H 1R3, Canada
– sequence: 3
  givenname: Xike
  surname: Qin
  fullname: Qin, Xike
  organization: Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, Quebec H4H 1R3, Canada
– sequence: 4
  givenname: Yunling
  surname: Wang
  fullname: Wang, Yunling
  organization: Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, Quebec H4H 1R3, Canada
– sequence: 5
  givenname: Hemant K.
  surname: Paudel
  fullname: Paudel, Hemant K.
  email: hemant.paudel@mcgill.ca
  organization: Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, Quebec H4H 1R3, Canada
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29577984$$D View this record in MEDLINE/PubMed
BookMark eNp9kcuOFSEQhokZ41z0AdwYlm66hb7RxJU50RnjJC7UNaGhjsNJNxy5TNLv4NP4ID7TVHtGl4YQqsj3_1BVl-TMBw-EvOSs5owPbw71YnzdMD7WrK0Zk0_IBWeyr2TbiLMt7rpKdC0_J5cpHRhjfSPbZ-S8kb0QcuwuyM_dmrLOztMdPcawhAyJZl22JANeH-9Cwh3XGangqfaWGl0SYoszCJWpzECdR5vJzS6vdFoxvXOTQ9vvGOaoDcxzmXWkuUQf7iHSsKfXXz61v38hQD2UGHx6Tp7u9ZzgxeN5Rb59eP91d1Pdfr7-uHt3W5lWyFyNTW8kt2A7MYoBuLDWtIZpM3T4EFi-F4Yz6Nk4DHvohZFS42rs0I0ja5r2irw--WKRPwqkrBaXti9qD6EktXV0GAbWcET5CcVSU4qwV8foFh1XxZnahqAOCofwR6JYq3AIqHn1aF-mBew_xd-uI_D2BAAWee8gqmQceAPWRTBZ2eD-Y_8AZBaeDw
CitedBy_id crossref_primary_10_3390_jcm11092372
crossref_primary_10_1111_cns_14818
crossref_primary_10_1016_j_mvr_2023_104510
Cites_doi 10.1074/jbc.M006219200
10.1038/nrneurol.2013.223
10.1073/pnas.0308512100
10.1212/WNL.57.2.337
10.1038/ng.2007.29
10.1097/00005072-199701000-00007
10.1073/pnas.83.13.4913
10.1016/j.brainres.2005.10.063
10.1073/pnas.122062299
10.1021/bi051634r
10.1212/WNL.57.2.366-a
10.1212/WNL.58.4.664
10.1016/0896-6273(93)90057-X
10.1073/pnas.092136199
10.1212/WNL.55.6.763
10.1007/s004010050513
10.1111/j.1365-2990.2006.00795.x
10.1074/jbc.M111.220962
10.1073/pnas.88.24.10998
10.1016/S0014-5793(97)01604-9
10.1042/bj2990219
10.1074/jbc.M206405200
10.1097/00005072-199909000-00011
10.1016/S0002-9440(10)61781-6
10.1016/j.jalz.2010.04.006
10.1111/j.1471-4159.2007.05194.x
10.1073/pnas.121119298
10.1212/01.WNL.0000151980.42337.44
10.1038/ng.2007.23
10.1074/jbc.M116.738849
10.1038/45159
10.1515/BC.2001.015
10.1128/MCB.02227-06
10.1126/science.1141736
10.1001/archneur.57.11.1579
10.1016/S0021-9258(18)67380-6
10.15252/emmm.201606210
10.1074/jbc.M606347200
10.1016/j.ajpath.2017.04.018
10.1159/000209278
10.1159/000125670
10.1093/emboj/20.1.27
10.1002/ana.20639
10.1038/nrn2494
10.1016/j.neurobiolaging.2013.01.008
10.1016/j.neurobiolaging.2003.11.006
10.1016/j.molmed.2009.01.003
10.1016/j.arr.2016.06.003
10.1016/S0896-6273(03)00434-3
10.1038/srep08187
ContentType Journal Article
Copyright 2018 Elsevier Inc.
Copyright © 2018 Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2018 Elsevier Inc.
– notice: Copyright © 2018 Elsevier Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.mcn.2018.03.009
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1095-9327
EndPage 8
ExternalDocumentID 10_1016_j_mcn_2018_03_009
29577984
S1044743117304037
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: CIHR
GroupedDBID ---
--K
--M
-DZ
-~X
.55
.~1
0R~
123
1B1
1RT
1~.
1~5
29M
3O-
4.4
457
4G.
53G
5VS
7-5
71M
85S
8P~
9JM
AABNK
AACTN
AADPK
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXLA
AAXUO
ABCQJ
ABFNM
ABFRF
ABGSF
ABJNI
ABMAC
ABUDA
ABXDB
ABYKQ
ACDAQ
ACGFO
ACGFS
ACRLP
ADBBV
ADEZE
ADFGL
ADMUD
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AFKWA
AFMIJ
AFTJW
AFXIZ
AGHFR
AGHSJ
AGRDE
AGUBO
AGWIK
AGYEJ
AHHHB
AHPSJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
C45
CAG
COF
CS3
DM4
DOVZS
DU5
EBS
EFBJH
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-Q
G8K
GBLVA
HLW
HMQ
HVGLF
HZ~
H~9
IH2
IHE
J1W
KOM
LG5
LX2
M2U
M41
MO0
MOBAO
N9A
O-L
O9-
OAUVE
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SBG
SCC
SDF
SDG
SDP
SES
SEW
SNS
SPCBC
SSN
SSU
SSZ
T5K
TEORI
TN5
UHS
UNMZH
WUQ
X7M
XPP
YNT
YQT
ZGI
ZMT
ZU3
~G-
AAXKI
AFJKZ
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
ABDPE
CITATION
7X8
ID FETCH-LOGICAL-c379t-825c91ded47876e17ddc3c0ac64aceed1f7c10e50866fe57c99a9a92d64880223
ISSN 1044-7431
IngestDate Sun Sep 29 07:47:46 EDT 2024
Thu Nov 21 21:40:40 EST 2024
Wed Oct 16 00:51:18 EDT 2024
Fri Feb 23 02:29:33 EST 2024
IsPeerReviewed true
IsScholarly true
Keywords Tau phosphorylation

GSK3β
AD
NFTs
3xTg-AD mice
CysC
Cystatin C
Alzheimer's disease
Language English
License Copyright © 2018 Elsevier Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c379t-825c91ded47876e17ddc3c0ac64aceed1f7c10e50866fe57c99a9a92d64880223
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 29577984
PQID 2018666021
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_2018666021
crossref_primary_10_1016_j_mcn_2018_03_009
pubmed_primary_29577984
elsevier_sciencedirect_doi_10_1016_j_mcn_2018_03_009
PublicationCentury 2000
PublicationDate 2018-06-01
PublicationDateYYYYMMDD 2018-06-01
PublicationDate_xml – month: 06
  year: 2018
  text: 2018-06-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Molecular and cellular neuroscience
PublicationTitleAlternate Mol Cell Neurosci
PublicationYear 2018
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Grundke-Iqbal, Iqbal, Tung, Quinlan, Wisniewski, Binder (bb0075) 1986; 83
Hanger, Anderton, Noble (bb0080) 2009; 15
Helisalmi, Vakeva, Hiltunen, Soininen (bb0085) 2009; 27
Wang, Liu, Liang, Xing, Zhao, Qin, Shang, Li, Fang, Cao, Zhao, Chen (bb0245) 2016; 11
Iqbal, Grundke-Iqbal (bb0100) 2010; 6
Finckh, von der Kammer, Velden, Michel, Andresen, Deng, Zhang, Muller-Thomsen, Zuchowski, Menzer, Mann, Papassotiropoulos, Heun, Zurdel, Holst, Benussi, Stoppe, Reiss, Miserez, Staehelin, Rebeck, Hyman, Binetti, Hock, Growdon, Nitsch (bb0065) 2000; 57
Giacobini, Gold (bb0070) 2013; 9
Rapoport, Dawson, Binder, Vitek, Ferreira (bb0210) 2002; 99
Maruyama, Izumi, Oda, Torii, Morino, Toji, Sasaki, Terasawa, Nakamura, Kawakami (bb0150) 2001; 57
Abrahamson, Barrett, Salvesen, Grubb (bb0005) 1986; 261
Bertram, Tanzi (bb0015) 2008; 9
Li, Paudel (bb0125) 2006; 45
Li, Chalifour, Paudel (bb0130) 2007; 282
Mi, Pawlik, Sastre, Jung, Radvinsky, Klein, Sommer, Schmidt, Nixon, Mathews, Levy (bb0160) 2007; 39
Roberson, Scearce-Levie, Palop, Yan, Cheng, Wu, Gerstein, Yu, Mucke (bb0215) 2007; 316
Qin, Wang, Paudel (bb0205) 2017; 187
Loberg, Vesely, Brosius (bb0135) 2002; 277
Nijholt, Nolle, van Haastert, Edelijn, Toonen, Hoozemans, Scheper (bb0170) 2013; 34
Wang, Xie, Yang, Peng, Wang, Zhou, Li, Ma (bb0240) 2008; 25
Deng, Irizarry, Nitsch, Growdon, Rebeck (bb0050) 2001; 159
Blalock, Geddes, Chen, Porter, Markesbery, Landfield (bb0025) 2004; 101
Selkoe, Hardy (bb0230) 2016; 8
Alonso, Zaidi, Novak, Grundke-Iqbal, Iqbal (bb0010) 2001; 98
Iqbal, Flory, Khatoon, Soininen, Pirttila, Lehtovirta, Alafuzoff, Blennow, Andreasen, Vanmechelen, Grundke-Iqbal (bb0105) 2005; 58
Kaeser, Herzig, Coomaraswamy, Kilger, Selenica, Winkler, Staufenbiel, Levy, Grubb, Jucker (bb0115) 2007; 39
Pei, Tanaka, Tung, Braak, Iqbal, Grundke-Iqbal (bb0190) 1997; 56
Spittaels, Van den Haute, Van Dorpe, Geerts, Mercken, Bruynseels, Lasrado, Vandezande, Laenen, Boon, Van Lint, Vandenheede, Moechars, Loos, Van Leuven (bb0235) 2000; 275
Bramblett, Goedert, Jakes, Merrick, Trojanowski, Lee (bb0030) 1993; 10
Lu, Li, Qureshi, Han, Paudel (bb0140) 2011; 286
Nycander, Estrada, Mort, Abrahamson, Bjork (bb0175) 1998; 422
Leroy, Yilmaz, Brion (bb0120) 2007; 33
Roks, Cruts, Slooter, Dermaut, Hofman, Van Broeckhoven, Van Duijn (bb0220) 2001; 57
Mathews, Levy (bb0155) 2016; 32
Hooper, Killick, Lovestone (bb0095) 2008; 104
Crawford, Freeman, Schinka, Abdullah, Gold, Hartman, Krivian, Morris, Richards, Duara, Anand, Mullan (bb0045) 2000; 55
Nagai, Ryu, Terashima, Tanigawa, Wakabayashi, McLarnon, Kobayashi, Masuda, Kim (bb0165) 2005; 1066
Patrick, Zukerberg, Nikolic, de la Monte, Dikkes, Tsai (bb0185) 1999; 402
Watcharasit, Bijur, Zmijewski, Song, Zmijewska, Chen, Johnson, Jope (bb0250) 2002; 99
Diaz, Gross, Assfalg-Machleidt, Pfeiler, Gollmitzer, Gabrijelcic-Geiger, Stubbs, Fritz, Auerswald, Machleidt (bb0055) 2001; 382
Hongisto, Vainio, Thompson, Courtney, Coffey (bb0090) 2008; 28
Pei, Braak, Braak, Grundke-Iqbal, Iqbal, Winblad, Cowburn (bb0195) 1999; 58
Sastre, Calero, Pawlik, Mathews, Kumar, Danilov, Schmidt, Nixon, Frangione, Levy (bb0225) 2004; 25
Dodel, Du, Depboylu, Kurz, Eastwood, Farlow, Oertel, Muller, Riemenschneider (bb0060) 2002; 58
Oddo, Caccamo, Shepherd, Murphy, Golde, Kayed, Metherate, Mattson, Akbari, LaFerla (bb0180) 2003; 39
Yamaguchi, Ishiguro, Uchida, Takashima, Lemere, Imahori (bb0255) 1996; 92
Bjork, Pol, Raub-Segall, Abrahamson, Rowan, Mort (bb0020) 1994; 299
Cataldo, Paskevich, Kominami, Nixon (bb0035) 1991; 88
Jin, Yin, Yu, Cao, Gong, Iqbal, Ding, Gu, Liu (bb0110) 2015; 5
Cathcart, Huang, Lanham, Corder, Poduslo (bb0040) 2005; 64
Lucas, Hernandez, Gomez-Ramos, Moran, Hen, Avila (bb0145) 2001; 20
Qin, Wang, Paudel (bb0200) 2016; 291
Nycander (10.1016/j.mcn.2018.03.009_bb0175) 1998; 422
Roks (10.1016/j.mcn.2018.03.009_bb0220) 2001; 57
Selkoe (10.1016/j.mcn.2018.03.009_bb0230) 2016; 8
Iqbal (10.1016/j.mcn.2018.03.009_bb0105) 2005; 58
Cathcart (10.1016/j.mcn.2018.03.009_bb0040) 2005; 64
Maruyama (10.1016/j.mcn.2018.03.009_bb0150) 2001; 57
Iqbal (10.1016/j.mcn.2018.03.009_bb0100) 2010; 6
Yamaguchi (10.1016/j.mcn.2018.03.009_bb0255) 1996; 92
Hooper (10.1016/j.mcn.2018.03.009_bb0095) 2008; 104
Dodel (10.1016/j.mcn.2018.03.009_bb0060) 2002; 58
Pei (10.1016/j.mcn.2018.03.009_bb0190) 1997; 56
Hongisto (10.1016/j.mcn.2018.03.009_bb0090) 2008; 28
Lu (10.1016/j.mcn.2018.03.009_bb0140) 2011; 286
Crawford (10.1016/j.mcn.2018.03.009_bb0045) 2000; 55
Diaz (10.1016/j.mcn.2018.03.009_bb0055) 2001; 382
Oddo (10.1016/j.mcn.2018.03.009_bb0180) 2003; 39
Lucas (10.1016/j.mcn.2018.03.009_bb0145) 2001; 20
Patrick (10.1016/j.mcn.2018.03.009_bb0185) 1999; 402
Grundke-Iqbal (10.1016/j.mcn.2018.03.009_bb0075) 1986; 83
Giacobini (10.1016/j.mcn.2018.03.009_bb0070) 2013; 9
Nagai (10.1016/j.mcn.2018.03.009_bb0165) 2005; 1066
Rapoport (10.1016/j.mcn.2018.03.009_bb0210) 2002; 99
Bertram (10.1016/j.mcn.2018.03.009_bb0015) 2008; 9
Watcharasit (10.1016/j.mcn.2018.03.009_bb0250) 2002; 99
Helisalmi (10.1016/j.mcn.2018.03.009_bb0085) 2009; 27
Leroy (10.1016/j.mcn.2018.03.009_bb0120) 2007; 33
Spittaels (10.1016/j.mcn.2018.03.009_bb0235) 2000; 275
Jin (10.1016/j.mcn.2018.03.009_bb0110) 2015; 5
Nijholt (10.1016/j.mcn.2018.03.009_bb0170) 2013; 34
Li (10.1016/j.mcn.2018.03.009_bb0130) 2007; 282
Deng (10.1016/j.mcn.2018.03.009_bb0050) 2001; 159
Alonso (10.1016/j.mcn.2018.03.009_bb0010) 2001; 98
Cataldo (10.1016/j.mcn.2018.03.009_bb0035) 1991; 88
Abrahamson (10.1016/j.mcn.2018.03.009_bb0005) 1986; 261
Pei (10.1016/j.mcn.2018.03.009_bb0195) 1999; 58
Qin (10.1016/j.mcn.2018.03.009_bb0205) 2017; 187
Wang (10.1016/j.mcn.2018.03.009_bb0245) 2016; 11
Mathews (10.1016/j.mcn.2018.03.009_bb0155) 2016; 32
Loberg (10.1016/j.mcn.2018.03.009_bb0135) 2002; 277
Bramblett (10.1016/j.mcn.2018.03.009_bb0030) 1993; 10
Bjork (10.1016/j.mcn.2018.03.009_bb0020) 1994; 299
Sastre (10.1016/j.mcn.2018.03.009_bb0225) 2004; 25
Hanger (10.1016/j.mcn.2018.03.009_bb0080) 2009; 15
Blalock (10.1016/j.mcn.2018.03.009_bb0025) 2004; 101
Li (10.1016/j.mcn.2018.03.009_bb0125) 2006; 45
Roberson (10.1016/j.mcn.2018.03.009_bb0215) 2007; 316
Qin (10.1016/j.mcn.2018.03.009_bb0200) 2016; 291
Finckh (10.1016/j.mcn.2018.03.009_bb0065) 2000; 57
Wang (10.1016/j.mcn.2018.03.009_bb0240) 2008; 25
Kaeser (10.1016/j.mcn.2018.03.009_bb0115) 2007; 39
Mi (10.1016/j.mcn.2018.03.009_bb0160) 2007; 39
References_xml – volume: 261
  start-page: 11282
  year: 1986
  end-page: 11289
  ident: bb0005
  article-title: Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Grubb
– volume: 98
  start-page: 6923
  year: 2001
  end-page: 6928
  ident: bb0010
  article-title: Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  contributor:
    fullname: Iqbal
– volume: 9
  start-page: 768
  year: 2008
  end-page: 778
  ident: bb0015
  article-title: Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses
  publication-title: Nat. Rev. Neurosci.
  contributor:
    fullname: Tanzi
– volume: 57
  start-page: 1579
  year: 2000
  end-page: 1583
  ident: bb0065
  article-title: Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease
  publication-title: Arch. Neurol.
  contributor:
    fullname: Nitsch
– volume: 99
  start-page: 7951
  year: 2002
  end-page: 7955
  ident: bb0250
  article-title: Direct, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damage
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  contributor:
    fullname: Jope
– volume: 9
  start-page: 677
  year: 2013
  end-page: 686
  ident: bb0070
  article-title: Alzheimer disease therapy—moving from amyloid-beta to tau
  publication-title: Nat. Rev. Neurol.
  contributor:
    fullname: Gold
– volume: 402
  start-page: 615
  year: 1999
  end-page: 622
  ident: bb0185
  article-title: Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration
  publication-title: Nature
  contributor:
    fullname: Tsai
– volume: 275
  start-page: 41340
  year: 2000
  end-page: 41349
  ident: bb0235
  article-title: Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Van Leuven
– volume: 15
  start-page: 112
  year: 2009
  end-page: 119
  ident: bb0080
  article-title: Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
  publication-title: Trends Mol. Med.
  contributor:
    fullname: Noble
– volume: 286
  start-page: 20569
  year: 2011
  end-page: 20581
  ident: bb0140
  article-title: Early growth response 1 (Egr-1) regulates phosphorylation of microtubule-associated protein tau in mammalian brain
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Paudel
– volume: 32
  start-page: 38
  year: 2016
  end-page: 50
  ident: bb0155
  article-title: Cystatin C in aging and in Alzheimer's disease
  publication-title: Ageing Res. Rev.
  contributor:
    fullname: Levy
– volume: 104
  start-page: 1433
  year: 2008
  end-page: 1439
  ident: bb0095
  article-title: The GSK3 hypothesis of Alzheimer's disease
  publication-title: J. Neurochem.
  contributor:
    fullname: Lovestone
– volume: 27
  start-page: 318
  year: 2009
  end-page: 321
  ident: bb0085
  article-title: Flanking markers of cystatin c (CST3) gene do not show association with Alzheimer's disease
  publication-title: Dement. Geriatr. Cogn. Disord.
  contributor:
    fullname: Soininen
– volume: 83
  start-page: 4913
  year: 1986
  end-page: 4917
  ident: bb0075
  article-title: Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  contributor:
    fullname: Binder
– volume: 187
  start-page: 1828
  year: 2017
  end-page: 1847
  ident: bb0205
  article-title: Inhibition of early growth response 1 in the hippocampus alleviates neuropathology and improves cognition in an Alzheimer model with plaques and tangles
  publication-title: Am. J. Pathol.
  contributor:
    fullname: Paudel
– volume: 39
  start-page: 1440
  year: 2007
  end-page: 1442
  ident: bb0160
  article-title: Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models
  publication-title: Nat. Genet.
  contributor:
    fullname: Levy
– volume: 316
  start-page: 750
  year: 2007
  end-page: 754
  ident: bb0215
  article-title: Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model
  publication-title: Science
  contributor:
    fullname: Mucke
– volume: 20
  start-page: 27
  year: 2001
  end-page: 39
  ident: bb0145
  article-title: Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice
  publication-title: EMBO J.
  contributor:
    fullname: Avila
– volume: 57
  start-page: 337
  year: 2001
  end-page: 339
  ident: bb0150
  article-title: Lack of an association between cystatin C gene polymorphisms in Japanese patients with Alzheimer's disease
  publication-title: Neurology
  contributor:
    fullname: Kawakami
– volume: 11
  year: 2016
  ident: bb0245
  article-title: Cystatin C shifts APP processing from amyloid-beta production towards non-amyloidgenic pathway in brain endothelial cells
  publication-title: PLoS One
  contributor:
    fullname: Chen
– volume: 64
  start-page: 755
  year: 2005
  end-page: 757
  ident: bb0040
  article-title: Cystatin C as a risk factor for Alzheimer disease
  publication-title: Neurology
  contributor:
    fullname: Poduslo
– volume: 5
  start-page: 8187
  year: 2015
  ident: bb0110
  article-title: Truncation and activation of GSK-3beta by calpain I: a molecular mechanism links to tau hyperphosphorylation in Alzheimer's disease
  publication-title: Sci. Rep.
  contributor:
    fullname: Liu
– volume: 25
  start-page: 461
  year: 2008
  end-page: 464
  ident: bb0240
  article-title: Lack of an association between Alzheimer's disease and the cystatin C (CST3) gene G73A polymorphism in Mainland Chinese
  publication-title: Dement. Geriatr. Cogn. Disord.
  contributor:
    fullname: Ma
– volume: 8
  start-page: 595
  year: 2016
  end-page: 608
  ident: bb0230
  article-title: The amyloid hypothesis of Alzheimer's disease at 25 years
  publication-title: EMBO Mol. Med.
  contributor:
    fullname: Hardy
– volume: 58
  start-page: 1010
  year: 1999
  end-page: 1019
  ident: bb0195
  article-title: Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes
  publication-title: J. Neuropathol. Exp. Neurol.
  contributor:
    fullname: Cowburn
– volume: 101
  start-page: 2173
  year: 2004
  end-page: 2178
  ident: bb0025
  article-title: Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  contributor:
    fullname: Landfield
– volume: 159
  start-page: 1061
  year: 2001
  end-page: 1068
  ident: bb0050
  article-title: Elevation of cystatin C in susceptible neurons in Alzheimer's disease
  publication-title: Am. J. Pathol.
  contributor:
    fullname: Rebeck
– volume: 39
  start-page: 409
  year: 2003
  end-page: 421
  ident: bb0180
  article-title: Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction
  publication-title: Neuron
  contributor:
    fullname: LaFerla
– volume: 291
  start-page: 22276
  year: 2016
  end-page: 22287
  ident: bb0200
  article-title: Early growth response 1 (Egr-1) is a transcriptional activator of beta-secretase 1 (BACE-1) in the brain
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Paudel
– volume: 99
  start-page: 6364
  year: 2002
  end-page: 6369
  ident: bb0210
  article-title: Tau is essential to beta-amyloid-induced neurotoxicity
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  contributor:
    fullname: Ferreira
– volume: 33
  start-page: 43
  year: 2007
  end-page: 55
  ident: bb0120
  article-title: Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration
  publication-title: Neuropathol. Appl. Neurobiol.
  contributor:
    fullname: Brion
– volume: 56
  start-page: 70
  year: 1997
  end-page: 78
  ident: bb0190
  article-title: Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain
  publication-title: J. Neuropathol. Exp. Neurol.
  contributor:
    fullname: Grundke-Iqbal
– volume: 58
  start-page: 664
  year: 2002
  ident: bb0060
  article-title: A polymorphism in the cystatin C promoter region is not associated with an increased risk of AD
  publication-title: Neurology
  contributor:
    fullname: Riemenschneider
– volume: 282
  start-page: 6619
  year: 2007
  end-page: 6628
  ident: bb0130
  article-title: Phosphorylation of protein phosphatase 1 by cyclin-dependent protein kinase 5 during nerve growth factor-induced PC12 cell differentiation
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Paudel
– volume: 422
  start-page: 61
  year: 1998
  end-page: 64
  ident: bb0175
  article-title: Two-step mechanism of inhibition of cathepsin B by cystatin C due to displacement of the proteinase occluding loop
  publication-title: FEBS Lett.
  contributor:
    fullname: Bjork
– volume: 28
  start-page: 1515
  year: 2008
  end-page: 1527
  ident: bb0090
  article-title: The Wnt pool of glycogen synthase kinase 3beta is critical for trophic-deprivation-induced neuronal death
  publication-title: Mol. Cell. Biol.
  contributor:
    fullname: Coffey
– volume: 10
  start-page: 1089
  year: 1993
  end-page: 1099
  ident: bb0030
  article-title: Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding
  publication-title: Neuron
  contributor:
    fullname: Lee
– volume: 6
  start-page: 420
  year: 2010
  end-page: 424
  ident: bb0100
  article-title: Alzheimer's disease, a multifactorial disorder seeking multitherapies
  publication-title: Alzheimers Dement.
  contributor:
    fullname: Grundke-Iqbal
– volume: 277
  start-page: 41667
  year: 2002
  end-page: 41673
  ident: bb0135
  article-title: Enhanced glycogen synthase kinase-3beta activity mediates hypoxia-induced apoptosis of vascular smooth muscle cells and is prevented by glucose transport and metabolism
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Brosius
– volume: 55
  start-page: 763
  year: 2000
  end-page: 768
  ident: bb0045
  article-title: A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease
  publication-title: Neurology
  contributor:
    fullname: Mullan
– volume: 25
  start-page: 1033
  year: 2004
  end-page: 1043
  ident: bb0225
  article-title: Binding of cystatin C to Alzheimer's amyloid beta inhibits in vitro amyloid fibril formation
  publication-title: Neurobiol. Aging
  contributor:
    fullname: Levy
– volume: 58
  start-page: 748
  year: 2005
  end-page: 757
  ident: bb0105
  article-title: Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers
  publication-title: Ann. Neurol.
  contributor:
    fullname: Grundke-Iqbal
– volume: 1066
  start-page: 120
  year: 2005
  end-page: 128
  ident: bb0165
  article-title: Neuronal cell death induced by cystatin C in vivo and in cultured human CNS neurons is inhibited with cathepsin B
  publication-title: Brain Res.
  contributor:
    fullname: Kim
– volume: 57
  start-page: 366
  year: 2001
  end-page: 367
  ident: bb0220
  article-title: The cystatin C polymorphism is not associated with early onset Alzheimer's disease
  publication-title: Neurology
  contributor:
    fullname: Van Duijn
– volume: 92
  start-page: 232
  year: 1996
  end-page: 241
  ident: bb0255
  article-title: Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II
  publication-title: Acta Neuropathol.
  contributor:
    fullname: Imahori
– volume: 88
  start-page: 10998
  year: 1991
  end-page: 11002
  ident: bb0035
  article-title: Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  contributor:
    fullname: Nixon
– volume: 34
  start-page: 1759
  year: 2013
  end-page: 1771
  ident: bb0170
  article-title: Unfolded protein response activates glycogen synthase kinase-3 via selective lysosomal degradation
  publication-title: Neurobiol. Aging
  contributor:
    fullname: Scheper
– volume: 45
  start-page: 3125
  year: 2006
  end-page: 3133
  ident: bb0125
  article-title: Glycogen synthase kinase 3beta phosphorylates Alzheimer's disease-specific Ser396 of microtubule-associated protein tau by a sequential mechanism
  publication-title: Biochemistry
  contributor:
    fullname: Paudel
– volume: 299
  start-page: 219
  year: 1994
  end-page: 225
  ident: bb0020
  article-title: Differential changes in the association and dissociation rate constants for binding of cystatins to target proteinases occurring on N-terminal truncation of the inhibitors indicate that the interaction mechanism varies with different enzymes
  publication-title: Biochem. J.
  contributor:
    fullname: Mort
– volume: 39
  start-page: 1437
  year: 2007
  end-page: 1439
  ident: bb0115
  article-title: Cystatin C modulates cerebral beta-amyloidosis
  publication-title: Nat. Genet.
  contributor:
    fullname: Jucker
– volume: 382
  start-page: 97
  year: 2001
  end-page: 107
  ident: bb0055
  article-title: Cystatins as calpain inhibitors: engineered chicken cystatin- and stefin B-kininogen domain 2 hybrids support a cystatin-like mode of interaction with the catalytic subunit of mu-calpain
  publication-title: Biol. Chem.
  contributor:
    fullname: Machleidt
– volume: 275
  start-page: 41340
  year: 2000
  ident: 10.1016/j.mcn.2018.03.009_bb0235
  article-title: Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M006219200
  contributor:
    fullname: Spittaels
– volume: 9
  start-page: 677
  year: 2013
  ident: 10.1016/j.mcn.2018.03.009_bb0070
  article-title: Alzheimer disease therapy—moving from amyloid-beta to tau
  publication-title: Nat. Rev. Neurol.
  doi: 10.1038/nrneurol.2013.223
  contributor:
    fullname: Giacobini
– volume: 101
  start-page: 2173
  year: 2004
  ident: 10.1016/j.mcn.2018.03.009_bb0025
  article-title: Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.0308512100
  contributor:
    fullname: Blalock
– volume: 57
  start-page: 337
  year: 2001
  ident: 10.1016/j.mcn.2018.03.009_bb0150
  article-title: Lack of an association between cystatin C gene polymorphisms in Japanese patients with Alzheimer's disease
  publication-title: Neurology
  doi: 10.1212/WNL.57.2.337
  contributor:
    fullname: Maruyama
– volume: 39
  start-page: 1440
  year: 2007
  ident: 10.1016/j.mcn.2018.03.009_bb0160
  article-title: Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models
  publication-title: Nat. Genet.
  doi: 10.1038/ng.2007.29
  contributor:
    fullname: Mi
– volume: 56
  start-page: 70
  year: 1997
  ident: 10.1016/j.mcn.2018.03.009_bb0190
  article-title: Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain
  publication-title: J. Neuropathol. Exp. Neurol.
  doi: 10.1097/00005072-199701000-00007
  contributor:
    fullname: Pei
– volume: 83
  start-page: 4913
  year: 1986
  ident: 10.1016/j.mcn.2018.03.009_bb0075
  article-title: Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.83.13.4913
  contributor:
    fullname: Grundke-Iqbal
– volume: 1066
  start-page: 120
  year: 2005
  ident: 10.1016/j.mcn.2018.03.009_bb0165
  article-title: Neuronal cell death induced by cystatin C in vivo and in cultured human CNS neurons is inhibited with cathepsin B
  publication-title: Brain Res.
  doi: 10.1016/j.brainres.2005.10.063
  contributor:
    fullname: Nagai
– volume: 99
  start-page: 7951
  year: 2002
  ident: 10.1016/j.mcn.2018.03.009_bb0250
  article-title: Direct, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damage
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.122062299
  contributor:
    fullname: Watcharasit
– volume: 45
  start-page: 3125
  year: 2006
  ident: 10.1016/j.mcn.2018.03.009_bb0125
  article-title: Glycogen synthase kinase 3beta phosphorylates Alzheimer's disease-specific Ser396 of microtubule-associated protein tau by a sequential mechanism
  publication-title: Biochemistry
  doi: 10.1021/bi051634r
  contributor:
    fullname: Li
– volume: 57
  start-page: 366
  year: 2001
  ident: 10.1016/j.mcn.2018.03.009_bb0220
  article-title: The cystatin C polymorphism is not associated with early onset Alzheimer's disease
  publication-title: Neurology
  doi: 10.1212/WNL.57.2.366-a
  contributor:
    fullname: Roks
– volume: 58
  start-page: 664
  year: 2002
  ident: 10.1016/j.mcn.2018.03.009_bb0060
  article-title: A polymorphism in the cystatin C promoter region is not associated with an increased risk of AD
  publication-title: Neurology
  doi: 10.1212/WNL.58.4.664
  contributor:
    fullname: Dodel
– volume: 10
  start-page: 1089
  year: 1993
  ident: 10.1016/j.mcn.2018.03.009_bb0030
  article-title: Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding
  publication-title: Neuron
  doi: 10.1016/0896-6273(93)90057-X
  contributor:
    fullname: Bramblett
– volume: 99
  start-page: 6364
  year: 2002
  ident: 10.1016/j.mcn.2018.03.009_bb0210
  article-title: Tau is essential to beta-amyloid-induced neurotoxicity
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.092136199
  contributor:
    fullname: Rapoport
– volume: 55
  start-page: 763
  year: 2000
  ident: 10.1016/j.mcn.2018.03.009_bb0045
  article-title: A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease
  publication-title: Neurology
  doi: 10.1212/WNL.55.6.763
  contributor:
    fullname: Crawford
– volume: 92
  start-page: 232
  year: 1996
  ident: 10.1016/j.mcn.2018.03.009_bb0255
  article-title: Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II
  publication-title: Acta Neuropathol.
  doi: 10.1007/s004010050513
  contributor:
    fullname: Yamaguchi
– volume: 33
  start-page: 43
  year: 2007
  ident: 10.1016/j.mcn.2018.03.009_bb0120
  article-title: Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration
  publication-title: Neuropathol. Appl. Neurobiol.
  doi: 10.1111/j.1365-2990.2006.00795.x
  contributor:
    fullname: Leroy
– volume: 286
  start-page: 20569
  year: 2011
  ident: 10.1016/j.mcn.2018.03.009_bb0140
  article-title: Early growth response 1 (Egr-1) regulates phosphorylation of microtubule-associated protein tau in mammalian brain
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M111.220962
  contributor:
    fullname: Lu
– volume: 88
  start-page: 10998
  year: 1991
  ident: 10.1016/j.mcn.2018.03.009_bb0035
  article-title: Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.88.24.10998
  contributor:
    fullname: Cataldo
– volume: 422
  start-page: 61
  year: 1998
  ident: 10.1016/j.mcn.2018.03.009_bb0175
  article-title: Two-step mechanism of inhibition of cathepsin B by cystatin C due to displacement of the proteinase occluding loop
  publication-title: FEBS Lett.
  doi: 10.1016/S0014-5793(97)01604-9
  contributor:
    fullname: Nycander
– volume: 299
  start-page: 219
  issue: Pt 1
  year: 1994
  ident: 10.1016/j.mcn.2018.03.009_bb0020
  article-title: Differential changes in the association and dissociation rate constants for binding of cystatins to target proteinases occurring on N-terminal truncation of the inhibitors indicate that the interaction mechanism varies with different enzymes
  publication-title: Biochem. J.
  doi: 10.1042/bj2990219
  contributor:
    fullname: Bjork
– volume: 277
  start-page: 41667
  year: 2002
  ident: 10.1016/j.mcn.2018.03.009_bb0135
  article-title: Enhanced glycogen synthase kinase-3beta activity mediates hypoxia-induced apoptosis of vascular smooth muscle cells and is prevented by glucose transport and metabolism
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M206405200
  contributor:
    fullname: Loberg
– volume: 58
  start-page: 1010
  year: 1999
  ident: 10.1016/j.mcn.2018.03.009_bb0195
  article-title: Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes
  publication-title: J. Neuropathol. Exp. Neurol.
  doi: 10.1097/00005072-199909000-00011
  contributor:
    fullname: Pei
– volume: 159
  start-page: 1061
  year: 2001
  ident: 10.1016/j.mcn.2018.03.009_bb0050
  article-title: Elevation of cystatin C in susceptible neurons in Alzheimer's disease
  publication-title: Am. J. Pathol.
  doi: 10.1016/S0002-9440(10)61781-6
  contributor:
    fullname: Deng
– volume: 6
  start-page: 420
  year: 2010
  ident: 10.1016/j.mcn.2018.03.009_bb0100
  article-title: Alzheimer's disease, a multifactorial disorder seeking multitherapies
  publication-title: Alzheimers Dement.
  doi: 10.1016/j.jalz.2010.04.006
  contributor:
    fullname: Iqbal
– volume: 104
  start-page: 1433
  year: 2008
  ident: 10.1016/j.mcn.2018.03.009_bb0095
  article-title: The GSK3 hypothesis of Alzheimer's disease
  publication-title: J. Neurochem.
  doi: 10.1111/j.1471-4159.2007.05194.x
  contributor:
    fullname: Hooper
– volume: 98
  start-page: 6923
  year: 2001
  ident: 10.1016/j.mcn.2018.03.009_bb0010
  article-title: Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.121119298
  contributor:
    fullname: Alonso
– volume: 64
  start-page: 755
  year: 2005
  ident: 10.1016/j.mcn.2018.03.009_bb0040
  article-title: Cystatin C as a risk factor for Alzheimer disease
  publication-title: Neurology
  doi: 10.1212/01.WNL.0000151980.42337.44
  contributor:
    fullname: Cathcart
– volume: 39
  start-page: 1437
  year: 2007
  ident: 10.1016/j.mcn.2018.03.009_bb0115
  article-title: Cystatin C modulates cerebral beta-amyloidosis
  publication-title: Nat. Genet.
  doi: 10.1038/ng.2007.23
  contributor:
    fullname: Kaeser
– volume: 291
  start-page: 22276
  year: 2016
  ident: 10.1016/j.mcn.2018.03.009_bb0200
  article-title: Early growth response 1 (Egr-1) is a transcriptional activator of beta-secretase 1 (BACE-1) in the brain
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M116.738849
  contributor:
    fullname: Qin
– volume: 402
  start-page: 615
  year: 1999
  ident: 10.1016/j.mcn.2018.03.009_bb0185
  article-title: Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration
  publication-title: Nature
  doi: 10.1038/45159
  contributor:
    fullname: Patrick
– volume: 382
  start-page: 97
  year: 2001
  ident: 10.1016/j.mcn.2018.03.009_bb0055
  article-title: Cystatins as calpain inhibitors: engineered chicken cystatin- and stefin B-kininogen domain 2 hybrids support a cystatin-like mode of interaction with the catalytic subunit of mu-calpain
  publication-title: Biol. Chem.
  doi: 10.1515/BC.2001.015
  contributor:
    fullname: Diaz
– volume: 28
  start-page: 1515
  year: 2008
  ident: 10.1016/j.mcn.2018.03.009_bb0090
  article-title: The Wnt pool of glycogen synthase kinase 3beta is critical for trophic-deprivation-induced neuronal death
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.02227-06
  contributor:
    fullname: Hongisto
– volume: 316
  start-page: 750
  year: 2007
  ident: 10.1016/j.mcn.2018.03.009_bb0215
  article-title: Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model
  publication-title: Science
  doi: 10.1126/science.1141736
  contributor:
    fullname: Roberson
– volume: 57
  start-page: 1579
  year: 2000
  ident: 10.1016/j.mcn.2018.03.009_bb0065
  article-title: Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease
  publication-title: Arch. Neurol.
  doi: 10.1001/archneur.57.11.1579
  contributor:
    fullname: Finckh
– volume: 11
  year: 2016
  ident: 10.1016/j.mcn.2018.03.009_bb0245
  article-title: Cystatin C shifts APP processing from amyloid-beta production towards non-amyloidgenic pathway in brain endothelial cells
  publication-title: PLoS One
  contributor:
    fullname: Wang
– volume: 261
  start-page: 11282
  year: 1986
  ident: 10.1016/j.mcn.2018.03.009_bb0005
  article-title: Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(18)67380-6
  contributor:
    fullname: Abrahamson
– volume: 8
  start-page: 595
  year: 2016
  ident: 10.1016/j.mcn.2018.03.009_bb0230
  article-title: The amyloid hypothesis of Alzheimer's disease at 25 years
  publication-title: EMBO Mol. Med.
  doi: 10.15252/emmm.201606210
  contributor:
    fullname: Selkoe
– volume: 282
  start-page: 6619
  year: 2007
  ident: 10.1016/j.mcn.2018.03.009_bb0130
  article-title: Phosphorylation of protein phosphatase 1 by cyclin-dependent protein kinase 5 during nerve growth factor-induced PC12 cell differentiation
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M606347200
  contributor:
    fullname: Li
– volume: 187
  start-page: 1828
  year: 2017
  ident: 10.1016/j.mcn.2018.03.009_bb0205
  article-title: Inhibition of early growth response 1 in the hippocampus alleviates neuropathology and improves cognition in an Alzheimer model with plaques and tangles
  publication-title: Am. J. Pathol.
  doi: 10.1016/j.ajpath.2017.04.018
  contributor:
    fullname: Qin
– volume: 27
  start-page: 318
  year: 2009
  ident: 10.1016/j.mcn.2018.03.009_bb0085
  article-title: Flanking markers of cystatin c (CST3) gene do not show association with Alzheimer's disease
  publication-title: Dement. Geriatr. Cogn. Disord.
  doi: 10.1159/000209278
  contributor:
    fullname: Helisalmi
– volume: 25
  start-page: 461
  year: 2008
  ident: 10.1016/j.mcn.2018.03.009_bb0240
  article-title: Lack of an association between Alzheimer's disease and the cystatin C (CST3) gene G73A polymorphism in Mainland Chinese
  publication-title: Dement. Geriatr. Cogn. Disord.
  doi: 10.1159/000125670
  contributor:
    fullname: Wang
– volume: 20
  start-page: 27
  year: 2001
  ident: 10.1016/j.mcn.2018.03.009_bb0145
  article-title: Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice
  publication-title: EMBO J.
  doi: 10.1093/emboj/20.1.27
  contributor:
    fullname: Lucas
– volume: 58
  start-page: 748
  year: 2005
  ident: 10.1016/j.mcn.2018.03.009_bb0105
  article-title: Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers
  publication-title: Ann. Neurol.
  doi: 10.1002/ana.20639
  contributor:
    fullname: Iqbal
– volume: 9
  start-page: 768
  year: 2008
  ident: 10.1016/j.mcn.2018.03.009_bb0015
  article-title: Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses
  publication-title: Nat. Rev. Neurosci.
  doi: 10.1038/nrn2494
  contributor:
    fullname: Bertram
– volume: 34
  start-page: 1759
  year: 2013
  ident: 10.1016/j.mcn.2018.03.009_bb0170
  article-title: Unfolded protein response activates glycogen synthase kinase-3 via selective lysosomal degradation
  publication-title: Neurobiol. Aging
  doi: 10.1016/j.neurobiolaging.2013.01.008
  contributor:
    fullname: Nijholt
– volume: 25
  start-page: 1033
  year: 2004
  ident: 10.1016/j.mcn.2018.03.009_bb0225
  article-title: Binding of cystatin C to Alzheimer's amyloid beta inhibits in vitro amyloid fibril formation
  publication-title: Neurobiol. Aging
  doi: 10.1016/j.neurobiolaging.2003.11.006
  contributor:
    fullname: Sastre
– volume: 15
  start-page: 112
  year: 2009
  ident: 10.1016/j.mcn.2018.03.009_bb0080
  article-title: Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
  publication-title: Trends Mol. Med.
  doi: 10.1016/j.molmed.2009.01.003
  contributor:
    fullname: Hanger
– volume: 32
  start-page: 38
  year: 2016
  ident: 10.1016/j.mcn.2018.03.009_bb0155
  article-title: Cystatin C in aging and in Alzheimer's disease
  publication-title: Ageing Res. Rev.
  doi: 10.1016/j.arr.2016.06.003
  contributor:
    fullname: Mathews
– volume: 39
  start-page: 409
  year: 2003
  ident: 10.1016/j.mcn.2018.03.009_bb0180
  article-title: Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction
  publication-title: Neuron
  doi: 10.1016/S0896-6273(03)00434-3
  contributor:
    fullname: Oddo
– volume: 5
  start-page: 8187
  year: 2015
  ident: 10.1016/j.mcn.2018.03.009_bb0110
  article-title: Truncation and activation of GSK-3beta by calpain I: a molecular mechanism links to tau hyperphosphorylation in Alzheimer's disease
  publication-title: Sci. Rep.
  doi: 10.1038/srep08187
  contributor:
    fullname: Jin
SSID ssj0005293
Score 2.321033
Snippet In Alzheimer's disease (AD) tau protein hyperphosphorylation causes neurofibrillary tangle formation, microtubule instability and neurodegeneration....
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 1
SubjectTerms 3xTg-AD mice
Alzheimer Disease - metabolism
Alzheimer's disease
Animals
Cystatin C
Cystatin C - pharmacology
Glycogen Synthase Kinase 3 beta - metabolism
GSK3β
HEK293 Cells
Humans
Mice
Microtubules - drug effects
Microtubules - metabolism
Neurons - drug effects
Neurons - metabolism
PC12 Cells
Phosphorylation
Protein Processing, Post-Translational
Proteolysis
Rats
Tau phosphorylation
tau Proteins - metabolism
Title Cystatin C promotes tau protein phosphorylation and causes microtubule instability by inhibiting intracellular turnover of GSK3β in neurons
URI https://dx.doi.org/10.1016/j.mcn.2018.03.009
https://www.ncbi.nlm.nih.gov/pubmed/29577984
https://search.proquest.com/docview/2018666021
Volume 89
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6l7YULAsojvLRIlAOVq6xfax9DGihF4pIihZO1ttfUhTgosQ_-D_wafgi_iZl92G5FESChKFa0cnZXns8zs7PfzBLyPMLNqCIF7cf93PFZmjsCdKITcDeNcpZKpk6JOFnw98voeO7PRyNbIbhv-6-ShjaQNWbO_oW0u06hAX6DzOEKUofrH8l91mKOEObyIfcKBIE1HERzqAoyIGX8fL2F76bVJDid1yaaLdy2QnJe3aTNF6wkAt0o4myLHmpZnZdpWesEmHojMN6vCKxgsSpkgaLT-WbxzjuYzQ9euRhFUZUyTSzQHhllz-LVo9o-BjU1O5gdNzoyewoji7KPm6udhmbb6SdZHU6PuuitLoiwLD_3O04mHv6xwZIgn4ZBDhb1ZCwdebPZN5fIobCS9B30gLQtM2149qSn6w1YDa8PKTIqmg1t_S-NiI5nXBytMiyQyyJdBTfuLWbHY1zgFHAGDBSlP_H4DtlzQeOBwt2bvp0vTwdso1jnepgp2w12RTW8MtB1LtJ1SyDlCp3dIjfNGoZONfhuk5Gs7pD9aSXq9aqlL6hiFavtmn3yzeKRzqjFIwU8UoNHegWPFJBBNR7pAI90gEeatrTHI72ER2rxSNcFRTz--A43UIPFu-TD6_nZ7MQxJ4A4mcfj2oncIItZLnMsIRVKxvM887KJyEJfoHfHCp6xiYRFRhgWMuBZHAv4uHmIdgk833tkt1pX8gGhvAhYiByANEr9sAhEEIoJ9BnDSJ5MozF5aR968lUXekksA_IiAQklKKFk4iUgoTHxrVgS83poDzQBDP3ub8-sCBPQ4vhoRCXXzVbdFML0XDYm97Vsu1m4ccB5HPkP_23QR-RG_0Y9Jrv1ppFPyM42b54akP4EiWHRTg
link.rule.ids 315,782,786,27933,27934
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cystatin+C+promotes+tau+protein+phosphorylation+and+causes+microtubule+instability+by+inhibiting+intracellular+turnover+of+GSK3%CE%B2+in+neurons&rft.jtitle=Molecular+and+cellular+neuroscience&rft.au=Duan%2C+Jinhai&rft.au=Marcellus%2C+Kristen+A.&rft.au=Qin%2C+Xike&rft.au=Wang%2C+Yunling&rft.date=2018-06-01&rft.pub=Elsevier+Inc&rft.issn=1044-7431&rft.eissn=1095-9327&rft.volume=89&rft.spage=1&rft.epage=8&rft_id=info:doi/10.1016%2Fj.mcn.2018.03.009&rft.externalDocID=S1044743117304037
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1044-7431&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1044-7431&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1044-7431&client=summon